Symmetry Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,144
| Closed | -$278K | – | 108 |
|
|
2024
Q2 | $278K | Buy |
+1,144
| New | +$278K | 0.01% | 423 |
|
|
2024
Q1 | – | Sell |
-1,144
| Closed | -$224K | – | 539 |
|
|
2023
Q4 | $224K | Sell |
1,144
-187
| -14% | -$36.6K | 0.01% | 464 |
|
|
2023
Q3 | $236K | Hold |
1,331
| – | – | 0.01% | 479 |
|
|
2023
Q2 | $253K | Hold |
1,331
| – | – | 0.01% | 503 |
|
|
2023
Q1 | $267K | Hold |
1,331
| – | – | 0.01% | 472 |
|
|
2022
Q4 | $316K | Hold |
1,331
| – | – | 0.02% | 457 |
|
|
2022
Q3 | $266K | Buy |
+1,331
| New | +$266K | 0.02% | 475 |
|
|
2022
Q2 | – | Sell |
-1,331
| Closed | -$217K | – | 546 |
|
|
2022
Q1 | $217K | Hold |
1,331
| – | – | 0.01% | 554 |
|
|
2021
Q4 | $226K | Hold |
1,331
| – | – | 0.01% | 577 |
|
|
2021
Q3 | $264K | Hold |
1,331
| – | – | 0.02% | 580 |
|
|
2021
Q2 | $226K | Buy |
+1,331
| New | +$226K | 0.02% | 625 |
|